IFM Investors’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-110
Closed -$2.63K 655
2026
Q1
$2.63K Buy
+110
New +$2.69K ﹤0.01% 663
2023
Q2
Sell
-68,483
Closed -$644K 639
2023
Q1
$644K Buy
68,483
+1,189
+2% +$14K 0.01% 600
2022
Q4
$822K Buy
67,294
+6,000
+10% +$74.8K 0.01% 586
2022
Q3
$761K Hold
61,294
0.01% 588
2022
Q2
$1.2M Hold
61,294
0.02% 550
2022
Q1
$1.6M Buy
61,294
+8,624
+16% +$230K 0.02% 521
2021
Q4
$1.5M Sell
52,670
-1,147
-2% -$35.7K 0.03% 527
2021
Q3
$1.72M Sell
53,817
-5,258
-9% -$176K 0.04% 477
2021
Q2
$2.05M Buy
59,075
+9,972
+20% +$329K 0.04% 445
2021
Q1
$1.45M Buy
49,103
+10,278
+26% +$316K 0.04% 457
2020
Q4
$1.19M Buy
38,825
+6,770
+21% +$207K 0.04% 458
2020
Q3
$895K Buy
32,055
+2,963
+10% +$75.1K 0.04% 431
2020
Q2
$624K Sell
29,092
-8,273
-22% -$183K 0.03% 471
2020
Q1
$844K Sell
37,365
-1,163
-3% -$31.9K 0.04% 425
2019
Q4
$1.14M Sell
38,528
-169
-0.4% -$4.59K 0.04% 446
2019
Q3
$1.03M Buy
38,697
+21,146
+120% +$634K 0.04% 460
2019
Q2
$593K Buy
+17,551
New +$570K 0.03% 496

Other funds holding ELAN

IFM Investors's ELAN Position: Q2 2026 in Review

IFM Investors sold out of Elanco Animal Health (ELAN) in Q2 2026, closing a stake of 110 shares — an estimated $2.63K sold.

IFM Investors first reported a position in ELAN in Q2 2019 and held it in 17 quarters. The position peaked at $2.05M in Q2 2021. 97 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • IFM Investors reported no remaining Elanco Animal Health position as of Q2 2026 after selling out during the quarter.
  • IFM Investors sold 110 Elanco Animal Health shares in Q2 2026, an estimated $2.63K.
  • IFM Investors first reported a position in Elanco Animal Health in Q2 2019 and held it in 17 quarters.
  • IFM Investors's Elanco Animal Health position peaked at $2.05M in Q2 2021.
  • 97 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.